.
New from McKinsey & Company | After the short, sharp shock of Omicron, the pandemic phase of COVID-19 is ending for most locations, unless and until a significant new variant emerges. This update discusses what we’ve learned from Omicron, the prospects for the rest of 2022, and presents three potential criteria for defining COVID-19 as endemic. | | | | | McKinsey Insights - Get our latest thinking on your iPhone, iPad, or Android | | | | | This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy. | You received this email because you subscribed to our Healthcare Systems & Services alert list. | | Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007 | | | |
No comments:
Post a Comment